Overexpression and process optimization for enhancing L-alanine production in E. coli BL21 (DE3)
Archives of Microbiology · 2026-08 · 208 (8)
DOI: 10.1007/s00203-026-04934-2 ↗Kurz gefasst
Fachartikel in der Zeitschrift Archives of Microbiology, online erschienen am 08.05.2026. Verfasst von Anshula Sharma und 2 weiteren Autor:innen. Beteiligte Einrichtung: Systems Biology Laboratory, Department of Biotechnology and Food Technology, Punjabi University, Patiala, 147002, India. Hauptthemen laut MEDLINE: Escherichia coli, Alanine, Industrial Microbiology, Metabolic Engineering. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 28 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Systems Biology Laboratory, Department of Biotechnology and Food Technology, Punjabi University, Patiala, 147002, India.
- Regional Centre for Biotechnology, NCR Biotech Cluster, Faridabad, 121001, India.
- Department of Biotechnology, University Institute of Biotechnology, Chandigarh University, Mohali, 140413, India.
- Systems Biology Laboratory, Department of Biotechnology and Food Technology, Punjabi University, Patiala, 147002, India. baljinderkaur@pbi.ac.in.
Zitieren
APA
Sharma, A., Kumar, B., & Kaur, B. (2026). Overexpression and process optimization for enhancing L-alanine production in E. coli BL21 (DE3). Archives of Microbiology, 208(8). https://doi.org/10.1007/s00203-026-04934-2
Vancouver
Sharma A, Kumar B, Kaur B. Overexpression and process optimization for enhancing L-alanine production in E. coli BL21 (DE3). Archives of Microbiology. 2026;208(8). doi:10.1007/s00203-026-04934-2
BibTeX
@article{Sharma2026,
author = {Sharma, Anshula and Kumar, Balvir and Kaur, Baljinder},
title = {Overexpression and process optimization for enhancing L-alanine production in E. coli BL21 (DE3)},
journal = {Archives of Microbiology},
year = {2026},
volume = {208},
number = {8},
doi = {10.1007/s00203-026-04934-2}
}
EUVIMED